Advances in AI, genomics, and liquid biopsy are reshaping cancer care, but systemic gaps persist in access and funding, ...

Asembia’s AXS25 Summit covered a variety of relevant topics in the pharmaceutical industry, from the effects of the new ...

To safely and successfully use artificial intelligence (AI) tools in the pharmacy, credentialing bodies and professional associations will need to validate these tools for the individual pharmacist, ...

But artificial intelligence on its own will never deny a claim, assures the insurer’s chief digital and technology officer ...

As we stride further into 2025, the pharmacy industry faces a landscape teeming with challenges and opportunities. From tackling drug ...

Kathi Henson, senior vice president of patient services, nursing and quality at Orsini, spoke with MHE editors at this year’s ...

This article is authored by Fayazoddin Mohamad, senior regulatory compliance and pharmacy management expert, Rite Drugs LLC.

In 2025, pharmacy leaders are grappling with a billion-dollar question: how to deliver high-quality, patient-centered care amid financial strain, policy uncertainty, and rapid technological change.

The investor is raising money to start and build companies infused with artificial intelligence, then use them to buy more.